SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-20-000010
Filing Date
2020-02-11
Accepted
2020-02-11 08:08:05
Documents
3
Period of Report
2020-02-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kxemaprimedesignation.htm 8-K 28958
2 EXHIBIT 99.1 ex991-emaprimedesignation.htm EX-99.1 19238
3 phasebiologo2a02.jpg GRAPHIC 136353
  Complete submission text file 0001169245-20-000010.txt   231796
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 20594006
SIC: 2834 Pharmaceutical Preparations